This website uses cookies to improve your experience. Continue if you are OK with this or read more in our privacy policy. 

Nuvo Research and Apotex reach PENNSAID patent settlement


Canadian pharmaceutical firms Nuvo Research and Apotex have agreed a patent settlement allowing Apotex to launch a generic version of Nuvo’s arthritis treatment PENNSAID in the US in April 2014 or earlier under certain circumstances.

Nuvo Research, Apotex, PENNSAID, generics, patent settlement


Payment types accepted